Glenn N. Levine, MD
Co-Chair
|
|
You need to upgrade your Flash Player
|
Current Literature
|
|





 |
|
Intravenous Platelet Blockade with Cangrelor during PCI
Bhatt DL, Lincoff AM, Gibson CM, et al; for the CHAMPION PLATFORM Investigators.
N Engl J Med.
2009; Nov 15. Epub ahead of print.
KEYWORDS:
Cardiovascular
Click for Full Abstract
|
|

 |
|
Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)
Boden WE, O'Rourke RA, Teo KK, et al; for the COURAGE Trial Investigators.
Am J Cardiol.
2009;104(1):1-4.
KEYWORDS:
Percutaneous Coronary Intervention
Click for Full Abstract
|
|




 |
|
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non–ST-segment elevation acute coronary syndrome. Primary results of the DISPERSE-2 Trial
Cannon CP et al.
J Am Coll Cardiol.
2007;50:1844-1851.
KEYWORDS:
Acute Coronary Syndrome
,
Cardiovascular
,
Hemorrhage
,
Myocardial Infarction
,
Percutaneous Coronary Intervention
,
Pharmacologic Therapy
|
|




















 |
|
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits PC.
Lancet.
2010 Jan 7. [Epub ahead of print]
KEYWORDS:
Drug-Eluting Stents
Click for Full Abstract
|
|

| | |